位置:首页 > 产品库 > C18 Ceramide-d3(d18:1/18:0-d3)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
C18 Ceramide-d3(d18:1/18:0-d3)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
C18 Ceramide-d3(d18:1/18:0-d3)图片
包装:1mg
规格:98%
市场价:5186元
分子量:569

An internal standard for the quantification of C18 ceramide
货号:ajcx21902
CAS:2011762-82-4
分子式:C36H68D3NO3
分子量:569
溶解度:Chloroform: Soluble,DMF: Soluble,Ethanol: Warmed
纯度:98%
存储:Store at -20°C
库存:现货

Background:

C18 Ceramide-d3(d18:1/18:0) is intended for use as an internal standard for the quantification of C18 Ceramide (d18:1/18:0) by GC- or LC-MS. C18 Ceramide is an endogenous bioactive sphingolipid. It is the primary short-chain ceramide found in brain tissue whose synthesis is regulated by longevity-assurance homologue 1 (Lass1) in mice.1Increased expression of C18 ceramide reduces cell growth in UM-SCC-22A squamous cell carcinoma cells.2It is selectively downregulated in 32 human head and neck squamous cell carcinoma tumor tissues as compared to non-squamous tumor tissues. C18 Ceramide concentration is significantly higher in muscle tissue of type 2 diabetic patients compared with non-diabetic patients and is positively correlated to body mass index and inversely related to insulin sensitivity.3[Matreya, LLC. Catalog No. 2201]


1.Mizutani, Y., Kihara, A., and Igarashi, Y.Mammalian Lass6 and its related family members regulate synthesis of specific ceramidesBiochem J.390(Pt. 1)263-271(2005) 2.Koybasi, S., Senkal, C.E., Sundararaj, K., et al.Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomasJ. Biol. Chem.279(43)44311-44319(2004) 3.Bergman, B.C., Brozinick, J.T., Strauss, A., et al.Muscle sphingolipids during rest and exercise: A C18:0 signature for insulin resistance in humansDiabetologia59(3)785-791(2016)

 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024